Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2014
04/10/2014WO2014005089A3 Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug substances
04/10/2014WO2014004664A3 Treatment of meningiomas using phenylbenzothiazole, stilbene, biphenylalkyne, or pyridine derivatives
04/10/2014WO2013192610A3 Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis
04/10/2014WO2013181488A3 Inhibition of leukemic stem cells by pp2a activating agents
04/10/2014WO2013171018A3 Mixtures having improved cooling effect
04/10/2014WO2013132485A9 Polymers having therapeutically active agents conjugated thereto, processes of preparing same and uses thereof
04/10/2014WO2013096182A3 Compositions comprising gallates and gallamides
04/10/2014WO2013055689A8 R(+)-n-methyl-propargyl-aminoindan
04/10/2014WO2013055684A8 Rasagiline citramide
04/10/2014WO2012142313A8 Micro-rna inhibitors and their uses in disease
04/10/2014WO2012103411A3 Controlled-release melatonin composition and related methods
04/10/2014WO2012087434A3 Use of phosphoric acid for treating cardiovascular disorders
04/10/2014WO2012083092A3 Bi-dentate compounds as kinase inhibitors
04/10/2014WO2012082647A3 PYRAZOLE INHIBITORS OF COX-2 AND sEH
04/10/2014WO2012078405A3 Methods and compositions for regulating gastric emptying
04/10/2014WO2012075117A3 Small molecule-polymer conjugates and methods of making same
04/10/2014WO2012075093A3 Topical formulations for administration of omega-3 fatty acids
04/10/2014WO2012075040A3 mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
04/10/2014WO2012074547A3 STEROID COMPOUNDS AS RORγt MODULATORS AND USES THEREOF
04/10/2014WO2012061019A3 Tricyclic mglur5 receptor modulators
04/10/2014WO2012058031A3 Novel method for preparation of bisnorcymerine and salts thereof
04/10/2014WO2012054527A3 Chemosensory receptor ligand-based therapies
04/10/2014WO2012054364A3 Bicyclic diamines as janus kinase inhibitors
04/10/2014US20140100537 Transdermal pharmaceutical preparation and administration of tirofiban
04/10/2014US20140100419 Active vitamin d or analogs thereof for use in in vivo or in vitro fertilization
04/10/2014US20140100290 Method of treating a prostate condition
04/10/2014US20140100289 Methods and compositions for treating mammalian nerve tissue injuries
04/10/2014US20140100287 Enhanced bimatoprost ophthalmic solution
04/10/2014US20140100286 Composition for preventing or treating inflammatory diseases comprising veratric acid as effective component
04/10/2014US20140100284 Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
04/10/2014US20140100283 Method to Increase Absorption and Bioavailability of Oral Glutathione
04/10/2014US20140100282 Intranasal administration of pharmaceutical agents for treatment of neurological diseases
04/10/2014US20140100281 Omega-3 pentaenoic acid compositions and methods of use
04/10/2014US20140100280 Treatment methods using very long chain polyunsaturated fatty acids
04/10/2014US20140100279 Extracts from eucalyptus camaldulensis for the treatment of hyperglycemia and hypertension
04/10/2014US20140100275 Methods of administering compositions comprising docosapentaenoic acid
04/10/2014US20140100274 Methods of administering compositions comprising docosapentaenoic acid
04/10/2014US20140100273 Methods of administering compositions comprising docosapentaenoic acid
04/10/2014US20140100272 Methods of administering compositions comprising docosapentaenoic acid
04/10/2014US20140100271 New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis
04/10/2014US20140100270 Radiation countermeasure agents
04/10/2014US20140100266 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia
04/10/2014US20140100264 Methods of treatment relating to the fmr1 gene
04/10/2014US20140100263 Methods for treatment of alport syndrome
04/10/2014US20140100262 Methods and Compositions for Maintaining Blood-Brain Barrier Integrity
04/10/2014US20140100261 Trpm-2 antisense therapy
04/10/2014US20140100260 Enalapril Compositions
04/10/2014US20140100258 Methods for treating degenerative diseases/injuries
04/10/2014US20140100257 Treatment or prevention of hypotension and shock
04/10/2014US20140100256 Formulations of enzalutamide
04/10/2014US20140100252 Amorphous ritonavir co-precipitated
04/10/2014US20140100249 Therapeutic Treatment
04/10/2014US20140100247 Method of treating apraxia of speech in children
04/10/2014US20140100246 Aclidinium for use in improving the quality of sleep in respiratory patents
04/10/2014US20140100244 Preventive And/Or Therapeutic Agent For Thromboembolism In Thromboembolism Patient With Severe Renal Impairment
04/10/2014US20140100241 Drug detoxification protocol using microdosing
04/10/2014US20140100239 Quinazolinedione derivatives as parp inhibitors
04/10/2014US20140100238 Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
04/10/2014US20140100232 Combination treatment for rosacea
04/10/2014US20140100231 Non-nucleoside reverse transcriptase inhibitors
04/10/2014US20140100229 Fluoroalkyl-substituted pyrazolopyridines and use thereof
04/10/2014US20140100225 Novel compounds, their preparation and their uses
04/10/2014US20140100222 Beta2-ADRENOCEPTOR AGONIST FOR THE TREATMENT OF COUGH
04/10/2014US20140100221 1H-Pyrrolo[2,3-b]Pyridine Derivatives
04/10/2014US20140100220 Novel compound useful for the treatment of degenerative and inflammatory diseases
04/10/2014US20140100219 Modified release preparations containing oxcarbazepine and derivatives thereof
04/10/2014US20140100218 Treatment of Mild and Moderate Alzheimer's Disease
04/10/2014US20140100216 Stimulators of incretin hormones secretion, method for preparation and use thereof
04/10/2014US20140100214 Heterocyclic compounds and uses thereof
04/10/2014US20140100208 Progesterone Antagonist and Selective Progesterone Modulator in the Treatment of Excessive Uterine Bleeding
04/10/2014US20140100207 Use of 19 nor dhea derivatives for enhancing physical performance
04/10/2014US20140100206 Natural combination hormone replacement formulations and therapies
04/10/2014US20140100205 Natural combination hormone replacement formulations and therapies
04/10/2014US20140100204 Natural combination hormone replacement formulations and therapies
04/10/2014US20140100203 Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration
04/10/2014US20140100202 Process for the preparation of a metal complex in an oily organic matrix
04/10/2014US20140100201 Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
04/10/2014US20140100200 Methods of treating acne
04/10/2014US20140100195 Heterobicyclic sphingosine 1-phosphate analogs
04/10/2014US20140100192 Pharmaceutical Formulation Containing Choline Alfoscerate
04/10/2014US20140100191 Vesicular Formulations
04/10/2014US20140100189 Carbohydrates mixture
04/10/2014US20140100187 Combinations of sapacitabine or cndac with dna methyltransferase inhibitors such as decitabine and procaine
04/10/2014US20140100185 Unit dosage of apadenoson
04/10/2014US20140100183 Central administration of stable formulations of therapeutic agents for cns conditions
04/10/2014US20140100182 Nanogel-Mediated Drug Delivery
04/10/2014US20140100181 Topical pharmaceutical composition containing a water-sensitive active principle
04/10/2014US20140100180 Topical pharmaceutical composition based on semifluorinated alkanes
04/10/2014US20140100177 Composition comprising cashew apple extract
04/10/2014US20140100176 L-sugar colon cleansing agent and uses thereof
04/10/2014US20140100174 Treatment for Cancer
04/10/2014US20140100163 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide
04/10/2014US20140099392 Phaleria macrocarpa extract, extraction process and its use as cholesteryl ester transferase protein (cetp) inhibitor
04/10/2014US20140099391 Synergistic salivation agents
04/10/2014US20140099390 Formulation of Curcumin With Enhanced Bioavailability of Curcumin and Method of Preparation and Treatment Thereof
04/10/2014US20140099389 Topical anti-inflammatory combination
04/10/2014US20140099387 Compositions and methods for treatment
04/10/2014US20140099386 Compositions and applications of carotenoids of improved absorption and bioavailability
04/10/2014US20140099385 Inhibition of fatty acid and cholesterol uptake by carbon monoxide (co)
04/10/2014US20140099382 Treatment using dantrolene
1 ... 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 ... 7860